Concepedia

Samir D. Undevia

SD

36

Publications

3.1K

Citations

24

H-Index

1996

Active since

Affiliations

University of Chicago(Current)

Cancer Research Center

Memorial Sloan Kettering Cancer Center

Washington University in St. Louis

University of Chicago Medical Center

Samir D. Undevia is an author at University of Chicago specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

1996–2019

36

Publications

36

Genetic Variants in the <i>UDP-glucuronosyltransferase 1A1</i> Gene Predict the Risk of Severe Neutropenia of Irinotecan

Federico Innocenti, Samir D. Undevia, Lalitha Iyer et al. · Journal of Clinical Oncology · 2004 · 946 citations · Full text

Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas

Robert G. Maki, David R. D’Adamo, Mary Louise Keohan et al. · Journal of Clinical Oncology · 2009 · 569 citations · Full text

, , +13

Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trial

Gary K. Schwartz, William D. Tap, Li-Xuan Qin et al. · The Lancet Oncology · 2013 · 186 citations · Full text

Ambulatory Monitoring Detects Sorafenib-Induced Blood Pressure Elevations on the First Day of Treatment

Michael L. Maitland, Kristen Kasza, Theodore Karrison et al. · Clinical Cancer Research · 2009 · 172 citations · Full text

Dose-Finding and Pharmacokinetic Study to Optimize the Dosing of Irinotecan According to the <i>UGT1A1</i> Genotype of Patients With Cancer

Federico Innocenti, Richard L. Schilsky, Jacqueline Ramı́rez et al. · Journal of Clinical Oncology · 2014 · 137 citations · Full text

Rows per page

1–5 of 36